Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Addition of Rosiglitazone to Insulin in Adolescents With Type 1 Diabetes and Poor Glycaemic Control: a Randomized, Placebo Controlled Trial

NCT00372086 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.

NCT NCT00372086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Addition of Rosiglitazone to Insulin in Adolescents With Type 1 Diabetes and Poor Glycaemic Control: a Randomized, Placebo Controlled Trial
Lead sponsor
The University of New South Wales
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2003
Completion date
September 30, 2005
Enrollment
32
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

puberty: >tanner 2 breast development or testis >4ml, type 1 diabetes